|
|
Volumn 8, Issue 2, 2016, Pages 103-106
|
|
Interview with Robert Coffin, inventor of T-VEC: The first oncolytic immunotherapy approved for the treatment of cancer
a
|
|
Author keywords
Imlygic; oncolytic immunotherapy; T VEC
|
|
Indexed keywords
TALIMOGENE LAHERPAREPVEC;
ONCOLYTIC VIRUS;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
DRUG APPROVAL;
DRUG USE;
FOOD AND DRUG ADMINISTRATION;
HEAD AND NECK CANCER;
HUMAN;
LONG TERM SURVIVAL;
LUNG CANCER;
MELANOMA;
ONCOLYTIC VIROTHERAPY;
OUTCOME ASSESSMENT;
PANCREAS CANCER;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
REVIEW;
TREATMENT RESPONSE;
ANIMAL;
ART;
HISTORY;
INTERVIEW;
PROCEDURES;
ANIMALS;
HISTORY, 21ST CENTURY;
HUMANS;
MELANOMA;
ONCOLYTIC VIROTHERAPY;
ONCOLYTIC VIRUSES;
PORTRAITS AS TOPIC;
|
|
EID: 84956943149
PISSN: 1750743X
EISSN: 17507448
Source Type: Journal
DOI: 10.2217/imt.15.116 Document Type: Review |
|
Times cited : (49)
|
|
References (0)
|
